Philadelphia Jury Returns $2.5M Risperdal Verdict

As reported in the Philadelphia Inquirer:

risperdalA Philadelphia jury said Tuesday [Feb. 24, 2015] that drugmaker Johnson & Johnson should pay $2.5 million to a 20-year-old autistic man from Alabama – who developed size 46 DD breasts as a young teenager – because the company failed to adequately warn of that potential side effect from his use of the antipsychotic drug Risperdal. This was the first case related to the condition called gynecomastia that went to a jury, but thousands more lawsuits are lined up in Philadelphia, California, Missouri, and other locations.

Read More Orange


HB Litigation Conferences Presents

Mass Tort Med School: A Bootcamp for Plaintiff Attorneys

Boca Raton

May 6-8, 2015




Categories: HB Risk Notes|Tags: |